700 SAGINAW DR, REDWOOD CITY, CA
Reports First Quarter 2026 Financial Results and Update on Corporate Progress
Revolution Medicines Issues $500 Million Convertible Senior Notes
Equity Offering - Revolution Medicines, Inc. Issues 10.56M Shares at $142
Other Events
Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
Financial Results, Press Release
Q1
FY 2024
Q3
Q2
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Definitive Merger Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
Free Writing Prospectus
Prospectus filed pursuant to Rule 305(b)(2)